Molecular Partners Ltd. | Income Statement
Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
32,417.70
26,625.10
29,119.00
23,040.00
20,016.00
10,355
Cost of Goods Sold (COGS) incl. D&A
21,415.10
21,236.20
-
-
1,145.00
-
Gross Income
11,002.60
5,388.80
-
-
18,871.00
-
SG&A Expense
3,789.70
3,286.30
30,428.00
41,437.00
44,715.00
46,841
EBIT
7,116.60
1,840.80
-
19,486.00
25,844.00
37,410
Unusual Expense
-
7,144.80
341.00
-
-
-
Non Operating Income/Expense
209.90
2,673.50
1,370.00
539.00
196.00
319
Pretax Income
7,141.50
2,282.80
149.00
18,612.00
25,430.00
37,036
Consolidated Net Income
7,141.50
2,282.80
149.00
18,612.00
25,430.00
37,036
Net Income
7,141.50
2,282.80
149.00
18,612.00
25,430.00
37,036
Net Income After Extraordinaries
7,141.50
2,282.80
149.00
18,612.00
25,430.00
37,036
Net Income Available to Common
7,141.50
2,282.80
149.00
18,612.00
25,430.00
37,036
EPS (Basic)
0.36
0.15
0.01
0.91
1.22
1.75
Basic Shares Outstanding
19,960.30
15,294.70
19,539.90
20,427.70
20,861.80
21,168.20
EPS (Diluted)
0.36
0.15
0.01
0.91
1.22
1.75
Diluted Shares Outstanding
19,960.30
15,294.70
19,539.90
20,427.70
20,861.80
21,168.20
EBITDA
7,909.60
2,650.30
1,309.00
18,397.00
24,699.00
36,486
Other Operating Expense
96.30
261.80
-
-
-
-
Non-Operating Interest Income
234.80
347.80
358.00
335.00
610.00
693
About Molecular Partners
View Profile
